Literature DB >> 12357349

Unrelated donor umbilical cord blood transplantation in adults.

M A Sanz1, G F Sanz.   

Abstract

Umbilical cord blood (UCB) has emerged as an appealing alternative source of hematopoietic stem cells for unrelated donor transplantation. Shorter time to transplant and an improved chance of finding a suitable graft are evident advantages over bone marrow transplantation from unrelated donors. The majority of UCB transplants from unrelated donors have been performed in children, but the number in adults has been growing steadily in recent years. We review herein the reported experience with that source of hematopoietic stem cells in adults with hematological malignancies. The available data support the use of UCB transplantation from unrelated donors for young adults with hematological malignancies and no appropriate bone marrow donor, especially for those requiring urgent transplantation.

Entities:  

Mesh:

Year:  2002        PMID: 12357349     DOI: 10.1038/sj.leu.2402688

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  8 in total

1.  Posttransplantation engraftment and safety of cord blood transplantation with grafts containing relatively low cell doses in adults.

Authors:  Satoshi Takahashi; Jun Ooi; Akira Tomonari; Takaaki Konuma; Nobuhiro Tsukada; Arinobu Tojo; Takuhiro Yamaguchi; Shigetaka Asano
Journal:  Int J Hematol       Date:  2006-11       Impact factor: 2.490

2.  Cost-effectiveness and clinical outcomes of double versus single cord blood transplantation in adults with acute leukemia in France.

Authors:  Myriam Labopin; Annalisa Ruggeri; Norbert Claude Gorin; Eliane Gluckman; Didier Blaise; Lionel Mannone; Noel Milpied; Ibrahim Yakoub-Agha; Eric Deconinck; Mauricette Michallet; Nathalie Fegueux; Gerard Socié; Stephanie Nguyen; Jean Yves Cahn; Thierry de Revel; Federico Garnier; Catherine Faucher; Namik Taright; Chantal Kenzey; Fernanda Volt; Dominique Bertrand; Mohamad Mohty; Vanderson Rocha
Journal:  Haematologica       Date:  2013-10-18       Impact factor: 9.941

3.  Human umbilical cord blood stem cells show PDGF-D-dependent glioma cell tropism in vitro and in vivo.

Authors:  Christopher S Gondi; Krishna Kumar Veeravalli; Bharathi Gorantla; Dzung H Dinh; Dan Fassett; Jeffrey D Klopfenstein; Meena Gujrati; Jasti S Rao
Journal:  Neuro Oncol       Date:  2010-01-22       Impact factor: 12.300

Review 4.  Transplantation of haploidentically mismatched stem cells for the treatment of malignant diseases.

Authors:  Franco Aversa; Massimo F Martelli
Journal:  Springer Semin Immunopathol       Date:  2004-09-11

5.  Hematopoietic stem cell transplantation across major genetic barriers.

Authors:  Yair Reisner
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

6.  Impact of hematopoietic chimerism at day +14 on engraftment after unrelated donor umbilical cord blood transplantation for hematologic malignancies.

Authors:  Federico Moscardó; Jaime Sanz; Leonor Senent; Susana Cantero; Javier de la Rubia; Pau Montesinos; Dolores Planelles; Ignacio Lorenzo; Jose Cervera; Javier Palau; Miguel A Sanz; Guillermo F Sanz
Journal:  Haematologica       Date:  2009-06       Impact factor: 9.941

Review 7.  Choice of Unmanipulated T Cell Replete Graft for Haploidentical Stem Cell Transplant and Posttransplant Cyclophosphamide in Hematologic Malignancies in Adults: Peripheral Blood or Bone Marrow-Review of Published Literature.

Authors:  Shatha Farhan; Edward Peres; Nalini Janakiraman
Journal:  Adv Hematol       Date:  2016-03-28

8.  Multiple allogeneic progenitors in combination function as a unit to support early transient hematopoiesis in transplantation.

Authors:  Takashi Ishida; Satoshi Takahashi; Chen-Yi Lai; Masanori Nojima; Ryo Yamamoto; Emiko Takeuchi; Yasuo Takeuchi; Masaaki Higashihara; Hiromitsu Nakauchi; Makoto Otsu
Journal:  J Exp Med       Date:  2016-08-08       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.